Venous thromboembolism in transgender women.
作者信息
Marques Marcos Arêas, Teruchkin Marcelo Melzer, de Oliveira André Luiz Malavasi Longo
机构信息
Universidade Federal do Estado do Rio de Janeiro - UNIRIO, Rio de Janeiro, RJ, Brasil.
Universidade do Estado do Rio de Janeiro - UERJ, Rio de Janeiro, RJ, Brasil.
出版信息
J Vasc Bras. 2023 Jan 13;21:e20220120. doi: 10.1590/1677-5449.202201201. eCollection 2022.
Abstract
摘要
相似文献
1
Venous thromboembolism in transgender women.跨性别女性中的静脉血栓栓塞症
J Vasc Bras. 2023 Jan 13;21:e20220120. doi: 10.1590/1677-5449.202201201. eCollection 2022.
2
Risk for Venous Thromboembolism in Transgender Patients Undergoing Cross-Sex Hormone Treatment: A Systematic Review.跨性别患者在接受跨性别激素治疗时发生静脉血栓栓塞的风险：系统评价。
J Sex Med. 2021 Jul;18(7):1280-1291. doi: 10.1016/j.jsxm.2021.04.006. Epub 2021 Jun 16.
3
Incidence of Venous Thromboembolism in Transgender Women Receiving Oral Estradiol.接受口服雌二醇治疗的跨性别女性静脉血栓栓塞的发生率。
J Sex Med. 2016 Nov;13(11):1773-1777. doi: 10.1016/j.jsxm.2016.09.001. Epub 2016 Sep 23.
4
Managing the risk of venous thromboembolism in transgender adults undergoing hormone therapy.管理接受激素治疗的成年跨性别者静脉血栓栓塞的风险。
J Blood Med. 2019 Jul 10;10:209-216. doi: 10.2147/JBM.S166780. eCollection 2019.
5
Venous Thrombotic Risk in Transgender Women Undergoing Estrogen Therapy: A Systematic Review and Metaanalysis. transgender 女性接受雌激素治疗的静脉血栓栓塞风险：系统评价和荟萃分析。
Clin Chem. 2019 Jan;65(1):57-66. doi: 10.1373/clinchem.2018.288316.
6
Transgender Medicine and Risk of Venous Thromboembolism. transgender 医学与静脉血栓栓塞风险。
Hamostaseologie. 2022 Oct;42(5):301-307. doi: 10.1055/a-1891-8158. Epub 2022 Nov 2.
7
[Hormone treatment of transgender people: Long-term health effects and safety].[跨性别者的激素治疗：长期健康影响与安全性]
Ned Tijdschr Geneeskd. 2020 Jul 23;164:D4481.
8
Hormone Therapy and Venous Thromboembolism in a Transgender Adolescent.一名青少年跨性别者的激素治疗与静脉血栓栓塞
J Pediatr Hematol Oncol. 2018 Jan;40(1):e38-e40. doi: 10.1097/MPH.0000000000000984.
9
Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons: A Cohort Study.跨性别者的性激素与急性心血管事件：一项队列研究。
Ann Intern Med. 2018 Aug 21;169(4):205-213. doi: 10.7326/M17-2785. Epub 2018 Jul 10.
10
Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.跨性别者接受激素 feminizing 治疗后的静脉血栓栓塞风险：一项患病率的荟萃分析和荟萃回归研究。
Front Endocrinol (Lausanne). 2021 Nov 9;12:741866. doi: 10.3389/fendo.2021.741866. eCollection 2021.
引用本文的文献
1
Guidelines on deep vein thrombosis of the Brazilian Society of Angiology and Vascular Surgery.巴西血管病学和血管外科学会深静脉血栓形成指南。
J Vasc Bras. 2024 Sep 3;23:e20230107. doi: 10.1590/1677-5449.202301072. eCollection 2024.
2
Venous thromboembolism in women.女性静脉血栓栓塞症
Rev Assoc Med Bras (1992). 2023 Aug 4;69(suppl 1):e2023S128. doi: 10.1590/1806-9282.2023S128. eCollection 2023.
本文引用的文献
1
Thrombosis Risk in Transgender Adolescents Receiving Gender-Affirming Hormone Therapy. transgender 青少年接受性别肯定激素治疗的血栓风险。
Pediatrics. 2021 Apr;147(4). doi: 10.1542/peds.2020-023549. Epub 2021 Mar 22.
2
Care of the Transgender Patient.跨性别患者护理。
Ann Intern Med. 2019 Jul 2;171(1):ITC1-ITC16. doi: 10.7326/AITC201907020.
3
Gender-Affirming Hormone Therapy for Transgender Females.针对跨性别女性的性别肯定激素疗法。
Clin Obstet Gynecol. 2018 Dec;61(4):705-721. doi: 10.1097/GRF.0000000000000396.
4
Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons: A Cohort Study.跨性别者的性激素与急性心血管事件：一项队列研究。
Ann Intern Med. 2018 Aug 21;169(4):205-213. doi: 10.7326/M17-2785. Epub 2018 Jul 10.
5
Hormone therapy in transgender adults is safe with provider supervision; A review of hormone therapy sequelae for transgender individuals.在医疗人员监督下，跨性别成年人的激素治疗是安全的；对跨性别者激素治疗后遗症的综述。
J Clin Transl Endocrinol. 2015 Jun;2(2):55-60. doi: 10.1016/j.jcte.2015.02.003.
6
Transgender people: health at the margins of society.跨性别者：社会边缘人群的健康问题
Lancet. 2016 Jul 23;388(10042):390-400. doi: 10.1016/S0140-6736(16)00683-8. Epub 2016 Jun 17.
7
Prevalence of Transgender Depends on the "Case" Definition: A Systematic Review.跨性别者的患病率取决于“病例”定义：一项系统综述。
J Sex Med. 2016 Apr;13(4):613-26. doi: 10.1016/j.jsxm.2016.02.001. Epub 2016 Mar 25.
8
Monitoring the health of transgender and other gender minority populations: validity of natal sex and gender identity survey items in a U.S. national cohort of young adults.监测跨性别者及其他性别少数群体的健康状况：美国年轻成年人全国队列中性别出生信息与性别认同调查项目的有效性
BMC Public Health. 2014 Nov 26;14:1224. doi: 10.1186/1471-2458-14-1224.
9
Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review.静脉血栓栓塞作为男性向女性变性者跨性别激素治疗的并发症：一项综述。
Andrologia. 2014 Sep;46(7):791-5. doi: 10.1111/and.12150. Epub 2013 Aug 15.
10
Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study.跨性别者在接受跨性别激素治疗期间患心血管疾病和癌症的流行情况：一项大型队列病例对照研究。
Eur J Endocrinol. 2013 Sep 13;169(4):471-8. doi: 10.1530/EJE-13-0493. Print 2013 Oct.
Zotero 插件